Paradigm Biopharmaceuticals (ASX:PAR) - Key People
ASX:PAR · Directors, executives and key personnel · 12 month lookback
Mentioned in
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Paradigm Completes Phase 3 Recruitment and Raises A$21.74m Ahead of Key Trial Milestones
28 Aug 2026
Healthcare Wrap - Week 30 (20 July -> 24 July) 2026
25 July 2026
Paradigm Secures $5.75 Million in Government R&D Refunds to Bolster Phase 3 Osteoarthritis Push
22 July 2026
Also Mentioned
People named in Paradigm Biopharmaceuticals (ASX:PAR) articles over the last 12 months, by frequency.
Simon White
· 29 articles
Hayden White
· 6 articles
Amos Meltzer
· 6 articles
Donna Skerrett
· 6 articles
Christopher Pattinson
· 5 articles
Cameron Morse
· 5 articles
James Dunne
· 5 articles
Matthew Fry
· 5 articles
Abby Macnish Niven
· 4 articles
Paradigm Board of Directors
· 3 articles
Chris Pattinson
· 2 articles
Melissa Kostopoulos
· 2 articles
A L Whittingh
· 2 articles
Catherine Stapledon
· 2 articles
Sanjiv Puri
· 2 articles
Melanie Duiker
· 2 articles
Melissa Kostopoulos, Senior Adviser, Listings Compliance
· 1 article
Abby Macnish Niven, Company Secretary
· 1 article
Abby Macnish
· 1 article